COVID-19 with essential thrombocythemia treated with apixaban for antithrombotic prophylaxis

A 40-year-old man was admitted to our hospital for COVID-19. He had been treated for essential thrombocythemia (ET). He was diagnosed severe illness of COVID-19, oxygen therapy and dexamethasone were administered. There was a possibility of thromboembolic events in this case, apixaban for prophylaxi...

Full description

Saved in:
Bibliographic Details
Published inBMJ case reports Vol. 14; no. 11; p. e246700
Main Authors Takasaki, Kazuki, Tsunenari, Takazumi, Mori, Kazuma, Aochi, Satsuki
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group LTD 30.11.2021
BMJ Publishing Group
Subjects
Blood
Blood platelets
Case Report
Case reports
Coronaviruses
COVID-19
Disease prevention
Drug dosages
Hospitals
Mortality
Patients
Severe acute respiratory syndrome coronavirus 2
Thromboembolism
Thrombosis
Tumors
Japan
Online AccessGet full text

Cover

Abstract A 40-year-old man was admitted to our hospital for COVID-19. He had been treated for essential thrombocythemia (ET). He was diagnosed severe illness of COVID-19, oxygen therapy and dexamethasone were administered. There was a possibility of thromboembolic events in this case, apixaban for prophylaxis was added. With these treatments, the patient has made a good recovery, and he was discharged on hospital day 11. There is no standard strategy for prophylaxis of thrombosis in patients with ET, and apixaban could be a clinical benefit for these patients.
AbstractList A 40-year-old man was admitted to our hospital for COVID-19. He had been treated for essential thrombocythemia (ET). He was diagnosed severe illness of COVID-19, oxygen therapy and dexamethasone were administered. There was a possibility of thromboembolic events in this case, apixaban for prophylaxis was added. With these treatments, the patient has made a good recovery, and he was discharged on hospital day 11. There is no standard strategy for prophylaxis of thrombosis in patients with ET, and apixaban could be a clinical benefit for these patients.
Author Takasaki, Kazuki
Tsunenari, Takazumi
Aochi, Satsuki
Mori, Kazuma
Author_xml – sequence: 1
  givenname: Kazuki
  surname: Takasaki
  fullname: Takasaki, Kazuki
– sequence: 2
  givenname: Takazumi
  surname: Tsunenari
  fullname: Tsunenari, Takazumi
– sequence: 3
  givenname: Kazuma
  surname: Mori
  fullname: Mori, Kazuma
– sequence: 4
  givenname: Satsuki
  surname: Aochi
  fullname: Aochi, Satsuki
BookMark eNpdkU1r3DAQhkVJaDbpnnM19NKLE31Zki-FsvmEwF6S0kNByPa41mJbrqRNsv8-2uwSkugygnnmZYbnGB2MbgSETgk-I4SJ86r2OcWU5JQLifEXNCOykLks8Z-Dd_8jNA9hhdNjhCvOvqIjlqritJihv4vl79uLnJTZk41dBiHAGK3ps9h5N1Su3sQOBmuy6MFEaHaYmeyzqcyYtc5nJg3s6WjrbPJu6ja9ebbhGzpsTR9gvq8n6OHq8n5xk98tr28Xv-7ympUq5qqBQlFqoKnbygDGiha4kQSwVKIoG1YUQIhSVOK2YUIC46LitRSC05aKhp2gn7vcaV0NKSWd4E2vJ28H4zfaGas_dkbb6X_uUSvBOOUyBfzYB3j3fw0h6sGGGvrejODWQVOBC8oILlVCv39CV27tx3TeK4W3KkSizndU7V0IHtq3ZQjWW3k6ydNbeXonj70A77eOLQ
CitedBy_id crossref_primary_10_31612_2616_4868_4_22__2022_13
crossref_primary_10_7759_cureus_62790
Cites_doi 10.1055/s-0040-1720978
10.1182/blood-2013-03-460154
10.1038/s41408-021-00417-3
10.7326/M17-0028
10.1007/s11481-020-09944-5
10.5551/jat.RPT001
10.1002/rth2.12439
10.1007/s11239-020-02146-z
ContentType Journal Article
Copyright This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage?
BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. 2021
Copyright_xml – notice: This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage?
– notice: BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. 2021
DBID AAYXX
CITATION
3V.
7RV
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
BTHHO
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
M1P
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1136/bcr-2021-246700
DatabaseName CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central
BMJ Journals
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
BMJ Journals
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest One Academic Eastern Edition
CrossRef
Database_xml – sequence: 1
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1757-790X
ExternalDocumentID 10_1136_bcr_2021_246700
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
0R~
23N
29B
3V.
4.4
53G
5GY
6J9
7RV
7X7
7~T
88E
8FI
8FJ
AAYAA
AAYXX
ABJNI
ABUWG
ABVAJ
ABWEH
ACGFS
ADBBV
ADCEG
ADMRH
AFKRA
AHMBA
AHQMW
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ASPBG
AVWKF
AZFZN
BENPR
BKEYQ
BPHCQ
BTHHO
BVXVI
C45
CCPQU
CITATION
EBS
EJD
FEDTE
FYUFA
GX1
H13
HAJ
HMCUK
HVGLF
HYE
HZ~
K-O
M1P
NAPCQ
NXWIF
O9-
OK1
OVD
PQQKQ
PROAC
PSQYO
RHI
RMJ
RPM
TEORI
UKHRP
7XB
8FK
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c398t-8de5822aedcfbae008250d71e078659d355e1188270fd367e346b4c76642f26d3
IEDL.DBID RPM
ISSN 1757-790X
IngestDate Tue Sep 17 21:26:42 EDT 2024
Thu Aug 15 23:41:38 EDT 2024
Thu Oct 10 17:42:24 EDT 2024
Fri Aug 23 01:40:14 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c398t-8de5822aedcfbae008250d71e078659d355e1188270fd367e346b4c76642f26d3
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ORCID 0000-0001-6671-1858
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634247/
PMID 34848425
PQID 2605046706
PQPubID 2040977
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8634247
proquest_miscellaneous_2605231098
proquest_journals_2605046706
crossref_primary_10_1136_bcr_2021_246700
PublicationCentury 2000
PublicationDate 2021-11-30
PublicationDateYYYYMMDD 2021-11-30
PublicationDate_xml – month: 11
  year: 2021
  text: 2021-11-30
  day: 30
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: BMA House, Tavistock Square, London, WC1H 9JR
PublicationTitle BMJ case reports
PublicationYear 2021
Publisher BMJ Publishing Group LTD
BMJ Publishing Group
Publisher_xml – name: BMJ Publishing Group LTD
– name: BMJ Publishing Group
References Horiuchi (2024051411383411000_14.11.e246700.5) 2021; 28
2024051411383411000_14.11.e246700.1
Hultcrantz (2024051411383411000_14.11.e246700.7) 2018; 168
2024051411383411000_14.11.e246700.4
2024051411383411000_14.11.e246700.6
Billett (2024051411383411000_14.11.e246700.9) 2020; 120
2024051411383411000_14.11.e246700.8
Nopp (2024051411383411000_14.11.e246700.2) 2020; 4
Barbui (2024051411383411000_14.11.e246700.3) 2021; 11
References_xml – volume: 120
  start-page: 1691
  year: 2020
  ident: 2024051411383411000_14.11.e246700.9
  article-title: Anticoagulation in COVID-19: effect of enoxaparin, heparin, and apixaban on mortality
  publication-title: Thromb Haemost
  doi: 10.1055/s-0040-1720978
  contributor:
    fullname: Billett
– ident: 2024051411383411000_14.11.e246700.6
  doi: 10.1182/blood-2013-03-460154
– volume: 11
  year: 2021
  ident: 2024051411383411000_14.11.e246700.3
  article-title: Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19
  publication-title: Blood Cancer J
  doi: 10.1038/s41408-021-00417-3
  contributor:
    fullname: Barbui
– volume: 168
  start-page: 317
  year: 2018
  ident: 2024051411383411000_14.11.e246700.7
  article-title: Risk for arterial and venous thrombosis in patients with myeloproliferative neoplasms: a population-based cohort study
  publication-title: Ann Intern Med
  doi: 10.7326/M17-0028
  contributor:
    fullname: Hultcrantz
– ident: 2024051411383411000_14.11.e246700.1
  doi: 10.1007/s11481-020-09944-5
– volume: 28
  start-page: 406
  year: 2021
  ident: 2024051411383411000_14.11.e246700.5
  article-title: COVID-19-Related thrombosis in Japan: final report of a questionnaire-based survey in 2020
  publication-title: J Atheroscler Thromb
  doi: 10.5551/jat.RPT001
  contributor:
    fullname: Horiuchi
– volume: 4
  start-page: 1178
  year: 2020
  ident: 2024051411383411000_14.11.e246700.2
  article-title: Risk of venous thromboembolism in patients with COVID‐19: a systematic review and meta‐analysis
  publication-title: Res Pract Thromb Haemost
  doi: 10.1002/rth2.12439
  contributor:
    fullname: Nopp
– ident: 2024051411383411000_14.11.e246700.4
– ident: 2024051411383411000_14.11.e246700.8
  doi: 10.1007/s11239-020-02146-z
SSID ssj0000314843
Score 2.2478566
Snippet A 40-year-old man was admitted to our hospital for COVID-19. He had been treated for essential thrombocythemia (ET). He was diagnosed severe illness of...
SourceID pubmedcentral
proquest
crossref
SourceType Open Access Repository
Aggregation Database
StartPage e246700
SubjectTerms Blood
Blood platelets
Case Report
Case reports
Coronaviruses
COVID-19
Disease prevention
Drug dosages
Hospitals
Mortality
Patients
Severe acute respiratory syndrome coronavirus 2
Thromboembolism
Thrombosis
Tumors
SummonAdditionalLinks – databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB50BfEiPnF9EcGDl2DbdJPmJD5RwQei4kEoSZPignZXdwX998602dW9eE5IwmSS-WYm-QZgV2sry6gsuCmN4qmLKL8rHbdxIdFaGKc79Dn56lqeP6SXT52nEHAbhGeVozuxvqhdr6AY-T7hbvTlVCQP-u-cqkZRdjWU0JiGmQQ9hagFM0en17d34ygLkbNnqQicPrGQ-7b4QM1IYp7QYNGkOfrFmJMvJP-YnLMFmA9YkR02m7sIU75agtmrkA1fhufjm8eLEx5rRtFURizgFR7YV0a1D95sr_gmStauYfVrcu-abqbf_TLWVAzhKjP0S7fpjZMwXBmK_dV8dQcr8HB2en98zkO1BF4InQ155nwHrb3BRZfW-Nr3i5yKPYIA2dEOgYVHbyJLVFQ6IZUXqbRpoSR6IGUinViFVtWr_BowK1yJMEEri86ULhDT-BRdH5tlOHIkkjbsjYSW9xtSjLx2JoTMUb45yTdv5NuGzZFQ83A6BvnvXrZhZ9yMek3JClP53mfTh7CnztqgJjZjPCUxY0-2VN2XmiE7kyJNUrX-_-QbMFdrQk3kuAmt4cen30KIMbTbQY9-AKcU0-s
  priority: 102
  providerName: ProQuest
Title COVID-19 with essential thrombocythemia treated with apixaban for antithrombotic prophylaxis
URI https://www.proquest.com/docview/2605046706
https://search.proquest.com/docview/2605231098
https://pubmed.ncbi.nlm.nih.gov/PMC8634247
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB7xkBCX1S4PURYqI3HgEprEjh0flwJiVyogBKgHpMiviEhtWtEiwb9n7KRAr3v2JLYmn-PvyzwCcCyl5mVcmkiVSkTMxj6-y22kE8PxtFBWZr44eXDNrx7Yv2E2XIFsUQsTkvaNrk7r0fi0rp5DbuV0bHqLPLHe7aCfc8pSJnqrsIoA_SbRw-uXIsNntG3jk1De0-YFwZAmUcp8UcombFC08PGn5cPoi2Eu50d-O3Auf8KPlimSP82KfsGKq7dgY9DGwrfhqX_z-Pc8SiTx31KJ7wFe43YdEf_ng7GemHffkLVSJOSSO9uYqWn1prSqCZJVonyNbmONkxBcGTp9pN6q2Q48XF7c96-i9l8JkaEyn0e5dRme9QoXXWrlgvKLrUgcUgCeSYu0wqGWyFMRl5Zy4SjjmhnBUX-UKbd0F9bqSe32gGhqSyQJUmiUUtIgo3EMhY_Oc7xzTNMOnCycVkyblhhFkBKUF-jqwru6aFzdgYOFU4t2b8wKr6BiP8w7cPQ5jKj2oQpVu8lrY-OZp8w7IJYexueUvi_28gjCJfTHbuGx_99X_obNgJfQ4fEA1uYvr-4QucdcdxFxQ9GF9bOL69u7bkDeB1153hs
link.rule.ids 230,315,730,783,787,888,12068,21400,27936,27937,31731,31732,33756,33757,43322,43817,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLZ4SMAF8RTjGSQOXCLapkuaE0I8NB6DC6AdkKqkScWk0Q02JPj32G032IVzoiRynPiznXwGONLayjzIM25yo3jsAsrvSsdtmEm0FsbpJn1Obt_L1lN802l26oDbsH5WOb4Ty4va9TOKkZ8Q7kZfTgXydPDOqWoUZVfrEhqzME88XFTBQHXUJMZC1OxJLGpGn1DIE5t9oF5EIY9oqGDaGP0izOn3kX8MztUKLNdIkZ1VW7sKM75Yg4V2nQtfh5fzh-frCx5qRrFURhzgBR7XHqPKB2-2n30TIWvXsPItuXdVNzPofhlrCoZglRn6o1v1xkkYrgyF3jNf3eEGPF1dPp63eF0rgWdCJyOeON9EW29w0bk1vvT8AqdCjxBANrVDWOHRl0giFeROSOVFLG2cKYn-Rx5JJzZhrugXfguYFS5HkKCVRVdKZ4hofIyOj00SHDkQUQOOx0JLBxUlRlq6EkKmKN-U5JtW8m3A7lioaX02hunvTjbgcNKMWk2pClP4_mfVh5CnThqgpjZjMiXxYk-3FN3Xkh87kSKOYrX9_-QHsNh6bN-ld9f3tzuwVGpFSem4C3Ojj0-_h2BjZPdLjfoBLnbVdg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bT9swGP3EQKp4YcA2UcbFk_awlzQXu078iMoqLivwMCY0TYp8i4ho0wpaCfj1fHZS1vLIs7_ESY4v58SfjwG-C6F4ERU6kIVMA2Yit77LTaBizXG2kEZ03ebkwQU_uWZnN92bhaO-fNK-VmWnGo46VXnrcysnIx3O88TCq0Ev45QlLA0npgg_wBr22YgvCHU_CFPk-Yw2Zj4x5aHS99gkkjhImNuasg4tihFuFWp5SvrPM5ezJBemnf5H-Dt_4Drb5K4zm6qOfn7j5fiuN9qEjYaMkqM6ZAtWbLUNrUGz3P4J_vUu_5weB7Eg7nctcTbjFY4IQ-IOVxipsX5ynq-lJD5d3Zo6TE7KR6lkRZAPE-m2AdfRWAnB90Bch_KxfPgM1_2fv3snQXMcQ6CpyKZBZmwX6YTEL1Ioab24jEwaW2QZvCsMMheLciVL0qgwlKeWMq6YTjlKnCLhhn6B1Wpc2R0gipoCeYhIFao1oZE0WYbaSmUZ3jmiSRt-zBHJJ7XrRu7VCuU54pg7HPMaxzbszRHLm-73kDuRFrli3oZvr8XYcdxqiKzseFbHOHIrsjakS0i_Vumst5dLED9vwd3gtfvuKw-hdXXcz3-dXpx_hXXfLr2f5B6sTu9ndh-ZzlQd-Db9AoMwACE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=COVID-19+with+essential+thrombocythemia+treated+with+apixaban+for+antithrombotic+prophylaxis&rft.jtitle=BMJ+case+reports&rft.au=Takasaki%2C+Kazuki&rft.au=Tsunenari%2C+Takazumi&rft.au=Mori%2C+Kazuma&rft.au=Aochi%2C+Satsuki&rft.date=2021-11-30&rft.pub=BMJ+Publishing+Group+LTD&rft.eissn=1757-790X&rft.volume=14&rft.issue=11&rft_id=info:doi/10.1136%2Fbcr-2021-246700
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1757-790X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1757-790X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1757-790X&client=summon